CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-16 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale | −4,902 | $75.17 | $368K | 23,713 |
| 2026-04-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion | +12,226 | 28,615 | ||
| 2026-04-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion · Restricted Stock Unit | −12,226 | 74,402 | ||
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion 10b5-1 | +32,602 | $46.10 | $1.5M | 48,991 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale 10b5-1 | −21,191 | $75.50 | $1.6M | 27,800 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale 10b5-1 | −16,086 | $76.30 | $1.2M | 11,714 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion 10b5-1 | +4,675 | $34.69 | $162K | 16,389 |
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −4,675 | 14,025 | ||
| 2026-03-10 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion · Non-Qualified Stock Option (right to buy) 10b5-1 | −32,602 | 32,601 | ||
| 2026-01-16 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale | −1,823 | $75.96 | $138K | 16,389 |
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion | +7,013 | 18,212 | ||
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Performance Restricted Stock Units | +25,800 | 44,500 | ||
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Restricted Stock Unit | +9,675 | 37,725 | ||
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion · Restricted Stock Unit | −7,013 | 29,664 | ||
| 2026-01-02 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Non-Qualified Stock Option (right to buy) | +19,350 | 19,350 | ||
| 2025-04-16 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Sale | −3,016 | $28.36 | $86K | 11,199 |
| 2025-04-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion | +12,226 | 14,215 | ||
| 2025-04-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Exercise or conversion · Restricted Stock Unit | −12,226 | 36,677 | ||
| 2025-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Performance Restricted Stock Units | +18,700 | 18,700 | ||
| 2025-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Restricted Stock Unit | +28,050 | 28,050 |
Page 1 of 1 · 20 trades